Hero with Background Image

Flex Rows (except Rich Content)

Optional text

Rich Content Example

Cards Row (3) - White

Personal Fundraiser FAQs

Cards Row (2) - Light

Personal Fundraiser FAQs

Cards Row (2) - Light

Personal Fundraiser FAQs

CTA Block - Light

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

CTA Block - Light

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

CTA Block - Light

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Flipcards - White

Our DEI Commitment

Heading text

Heading text

Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

About Us

Card Heading

Card Heading

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Personal Fundraiser FAQs

The heading of the card

The heading of the card

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation.

Glossary

Flipcards - Light

Our DEI Commitment

Heading text

Heading text

Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

About Us

Card Heading

Card Heading

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Personal Fundraiser FAQs

The heading of the card

The heading of the card

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation.

Glossary

Flipcards - Dark

Our DEI Commitment

Heading text

Heading text

Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

About Us

Card Heading

Card Heading

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Personal Fundraiser FAQs

The heading of the card

The heading of the card

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation.

Glossary

Logo Grid (6) - White

Logo Grid (6) - White

Logo Grid (6) - White

People Cards (3) (images Yes) - Light

  • Carolyn Zainer

    Founder and Owner of CAZ Designs, Inc

  • David Sturges

    Co-Founder & Treasurer Emeritus, Lung Cancer Foundation of America

  • David Carbone, MD, PhD

    Professor of Medicine in the Division of Medical Oncology, The Ohio State University – James Cancer Hospital and Solove Research Institute

  • Dr. David H. Johnson, MD

    Emeritus

    Donald W. Seldin Distinguished Chair in Internal Medicine at UT Southwestern Medical Center in Dallas, Texas

    Chairman of the Department of Internal Medicine at UT Southwestern Medical Center in Dallas, Texas

People Cards (3) (images Yes) - Light

  • Carolyn Zainer

    Founder and Owner of CAZ Designs, Inc

  • David Sturges

    Co-Founder & Treasurer Emeritus, Lung Cancer Foundation of America

  • David Carbone, MD, PhD

    Professor of Medicine in the Division of Medical Oncology, The Ohio State University – James Cancer Hospital and Solove Research Institute

  • Dr. David H. Johnson, MD

    Emeritus

    Donald W. Seldin Distinguished Chair in Internal Medicine at UT Southwestern Medical Center in Dallas, Texas

    Chairman of the Department of Internal Medicine at UT Southwestern Medical Center in Dallas, Texas

  • Donna Whitney

    Director of Digital Strategy & Web

  • David T. Levinson

    Founder/Executive Director – Big Sunday

People Cards (3) (images Yes) - Light

  • Carolyn Zainer

    Founder and Owner of CAZ Designs, Inc

  • David Sturges

    Co-Founder & Treasurer Emeritus, Lung Cancer Foundation of America

  • David Carbone, MD, PhD

    Professor of Medicine in the Division of Medical Oncology, The Ohio State University – James Cancer Hospital and Solove Research Institute

  • Dr. David H. Johnson, MD

    Emeritus

    Donald W. Seldin Distinguished Chair in Internal Medicine at UT Southwestern Medical Center in Dallas, Texas

    Chairman of the Department of Internal Medicine at UT Southwestern Medical Center in Dallas, Texas

  • Donna Whitney

    Director of Digital Strategy & Web

  • David T. Levinson

    Founder/Executive Director – Big Sunday

Researcher Cards

Homepage
  • Julie Wu, MD

    Staff Physician, Medical Oncology

    Precision oncology integrating evidence-based models into clinical practice to personalize treatment approaches

  • Aparna Sharma, DM

    Thoracic medical oncologist

    Genomic characterization of young onset lung adenocarcinoma

  • Jonathan Villena-Vargas, MD

    Thoracic Surgeon

    Characterizing T cell PD-1 response in the tumor-draining lymph nodes of early-stage NSCLC patients

  • Jarushka Naidoo, MRCPI

    Clinical/Translational Investigator

    Identifying novel biomarkers of response and toxicity to immunotherapy

Researcher Cards

Homepage
  • Julie Wu, MD

    Staff Physician, Medical Oncology

    Precision oncology integrating evidence-based models into clinical practice to personalize treatment approaches

  • Aparna Sharma, DM

    Thoracic medical oncologist

    Genomic characterization of young onset lung adenocarcinoma

  • Jonathan Villena-Vargas, MD

    Thoracic Surgeon

    Characterizing T cell PD-1 response in the tumor-draining lymph nodes of early-stage NSCLC patients

  • Jarushka Naidoo, MRCPI

    Clinical/Translational Investigator

    Identifying novel biomarkers of response and toxicity to immunotherapy

  • Triparna Sen, PhD

    Cell and molecular biologist

    Novel therapies for small cell lung cancer (SCLC)

Researcher Cards

Homepage
  • Julie Wu, MD

    Staff Physician, Medical Oncology

    Precision oncology integrating evidence-based models into clinical practice to personalize treatment approaches

  • Aparna Sharma, DM

    Thoracic medical oncologist

    Genomic characterization of young onset lung adenocarcinoma

  • Jonathan Villena-Vargas, MD

    Thoracic Surgeon

    Characterizing T cell PD-1 response in the tumor-draining lymph nodes of early-stage NSCLC patients

  • Jarushka Naidoo, MRCPI

    Clinical/Translational Investigator

    Identifying novel biomarkers of response and toxicity to immunotherapy

  • Triparna Sen, PhD

    Cell and molecular biologist

    Novel therapies for small cell lung cancer (SCLC)

  • Jon Zugazagoitia, MD, PhD

    Thoracic Oncology

    Developing precision immunotherapy strategies to improve outcomes of patients with NSCLC

  • Jacob Kaufman, Md, PhD

    Medical Oncology

    Understanding how the specific genetic background of each cancer affects their behaviors in patients

Label Text

Stats Columns (3) - White

34 Thingamabobs

$749M For research

7 Reasons to donate

Label Text

Stats Columns (3) - Light

34 Thingamabobs

$749M For research

7 Reasons to donate

Label Text

Stats Columns (6) - White

34 Thingamabobs

$749M For research

7 Reasons to donate

4Q To a gallon

12 Eggs in a carton

5,280 Feet in a mile

Label text

Feature (Teaser) - Image, Light, Right

Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Lorem ipsum dolor sit amet,

  • consectetur adipiscing elit
  • sed do eiusmod tempor
  • incididunt ut labore et dolore
Chemotherapy

Label text

Feature (Teaser) - Image, Light, Right

Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Lorem ipsum dolor sit amet,

  • consectetur adipiscing elit
  • sed do eiusmod tempor
  • incididunt ut labore et dolore
Chemotherapy

Label text

Feature (Teaser) - Image, Light, Right

Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Lorem ipsum dolor sit amet,

  • consectetur adipiscing elit
  • sed do eiusmod tempor
  • incididunt ut labore et dolore
Chemotherapy

Timeline Block

  • 2017

    January 1, 2017

    Celebrating LCFA’s 10-Year Anniversary

    Learn more
  • 2018

    August 1, 2018

    Launch of Hope With Answers video series

    Learn more
  • 2016

    June 1, 2016

    LCFA Announces the Class of 2016 Grant Award Recipients

    Learn more

Lorem ipsum

Treatment Cards - White

  • Chemotherapy

    Chemotherapy uses pills, medicines injected in your veins, or both to shrink or kill cancers. This treatment may be used alone or with radiation before or after surgery. Prepare for chemotherapy by learning what to expect.
  • Radiation

    Radiation therapy uses high-energy rays (similar to X-rays) to destroy cancer cells. The type of radiation therapy most often used to treat SCLC is called external beam radiation therapy (EBRT). Techniques include: Three-dimensional conformal radiation therapy (3D-CRT),  Intensity modulated radiation therapy (IMRT), and Stereotactic body radiation therapy (SBRT).
  • Surgery

    Surgery might be an option for early-stage non-small cell lung cancer (NSCLC). It typically provides the best chance to cure the disease at this stage.

Lorem ipsum

Treatment Cards - Light

  • Chemotherapy

    Chemotherapy uses pills, medicines injected in your veins, or both to shrink or kill cancers. This treatment may be used alone or with radiation before or after surgery. Prepare for chemotherapy by learning what to expect.
  • Radiation

    Radiation therapy uses high-energy rays (similar to X-rays) to destroy cancer cells. The type of radiation therapy most often used to treat SCLC is called external beam radiation therapy (EBRT). Techniques include: Three-dimensional conformal radiation therapy (3D-CRT),  Intensity modulated radiation therapy (IMRT), and Stereotactic body radiation therapy (SBRT).
  • Surgery

    Surgery might be an option for early-stage non-small cell lung cancer (NSCLC). It typically provides the best chance to cure the disease at this stage.

Lorem ipsum

Treatment Cards - Dark

  • Chemotherapy

    Chemotherapy uses pills, medicines injected in your veins, or both to shrink or kill cancers. This treatment may be used alone or with radiation before or after surgery. Prepare for chemotherapy by learning what to expect.
  • Radiation

    Radiation therapy uses high-energy rays (similar to X-rays) to destroy cancer cells. The type of radiation therapy most often used to treat SCLC is called external beam radiation therapy (EBRT). Techniques include: Three-dimensional conformal radiation therapy (3D-CRT),  Intensity modulated radiation therapy (IMRT), and Stereotactic body radiation therapy (SBRT).
  • Surgery

    Surgery might be an option for early-stage non-small cell lung cancer (NSCLC). It typically provides the best chance to cure the disease at this stage.

Video row caption

Optional Kicker

Video Row (dark bg)

Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Video row caption

Optional Kicker

Video Row (dark bg)

Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Video row caption

Optional Kicker

Video Row (dark bg)

Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

View all

Word of the Day

Phase IV clinical trial

The fourth stage of testing a new treatment or therapy after it has been approved and is available for public use. Phase IV trials gather additional information about long-term safety and effectiveness.

View all

Word of the Day

Phase IV clinical trial

The fourth stage of testing a new treatment or therapy after it has been approved and is available for public use. Phase IV trials gather additional information about long-term safety and effectiveness.

View all

Word of the Day

Phase IV clinical trial

The fourth stage of testing a new treatment or therapy after it has been approved and is available for public use. Phase IV trials gather additional information about long-term safety and effectiveness.